Innovative Diagnostic Platform Ohmx offers a unique and comprehensive point-of-care diagnostic system capable of analyzing DNA, proteins, and small molecules simultaneously from low-volume samples, addressing a significant market need for versatile and portable medical testing solutions.

Cost-Effective Screening The portable blood analyzer can enable healthcare providers to perform rapid, affordable screening and monitoring, which presents opportunities to expand sales within clinics, urgent care centers, and preventive medicine programs aiming to reduce overall healthcare costs.

Growing Market Potential With current revenues estimated between one and ten million dollars and ongoing funding of over three million dollars, Ohmx is positioned for growth, making it attractive to partners and distributors seeking innovative medical devices in the diagnostics space.

Targeting High-Impact Use Cases The device’s capability to quickly diagnose and monitor acute and chronic diseases offers a compelling proposition for hospitals, clinics, and home health markets looking to improve patient outcomes through rapid and precise testing at the point of care.

Emerging Market Opportunities Given the focus on low-cost, portable diagnostics and the increasing demand for decentralized testing, Ohmx has strong potential to penetrate developing markets and health systems seeking accessible and efficient medical testing solutions.